Gina Im

Gina joined Solebury Capital in 2005 and oversees all areas of administration for the firm and its affiliates. Her multifunctional responsibilities include business administration, financial operations, business risk and regulatory compliance.

Prior to joining the firm, Gina was with Acorda Therapeutics, a biotechnology company engaged in the development of drugs that restore neurological function for people with spinal cord injury and other central nervous system disorders. She was responsible for overseeing the direct activities of clinical research organizations (CROs) and vendors for data management, safety reporting, central labs, drug distribution, and statistical analysis of Phase II and Phase III clinical trials. She was also involved in the preparation of Annual Study Reports, Final Study Reports, and NDA submission to the Food and Drug Administration.

Gina earned her B.A. in Pharmacy and Pharm.D. from Rutgers University’s College of Pharmacy.